It is reported that increased ACE concentrations lead to increased levels of angiotensin II, which might be responsible for the severe lung injury in COVID-19 patients, while inhibiting the angiotensin II-signaling pathway and/or RAAS, through ACE2, has been shown to protect against lung damage [46]. The gene discussed is ACE2; the disease is COVID-19.